{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:59:05Z","timestamp":1777471145852,"version":"3.51.4"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Activated partial thromboplastin time (APTT) is susceptible to reagent composition. This study aimed to investigate a large number of specimens and determine the cause of discrepancies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Method<\/jats:title>\n                  <jats:p>This study included 18,994 subjects who underwent coagulation tests at our hospital from May 2020 to December 2020. Measuring reagents included HemosIL SynthASil APTT (APTT-SS, Instrumentation Laboratory) and Coagpia APTT-N (APTT-N, Sekisui Medical).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 451 patients demonstrated APTT-N of &amp;gt;39 seconds and an APTT-N\/SS ratio of &amp;gt;1.3. A C-reactive protein (CRP) level of \u22651.4\u202fmg\/L demonstrated a significant positive correlation, with a higher APTT-N\/SS indicating higher CRP levels. All 28 subjects receiving no anticoagulants and who had remaining specimens underwent a cross-mixing test (CMT). Of them, 17 were suspected for lupus anticoagulant (LA) by both the waveform shape and the index of circulating anticoagulant (ICA) value, 6 by the ICA value, and 5 were difficult to determine.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This study revealed that the APTT-N prolongation correlated with CRP degree and the transient involvement of LA in CMT results due to CRP. This study indicated various reactivities depending on the assay reagents used. Further testing is warranted if LA is suspected, considering the patient\u2019s background.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/labmed\/lmae053","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T20:10:19Z","timestamp":1725048619000},"page":"7-14","source":"Crossref","is-referenced-by-count":1,"title":["Difference in activated partial thromboplastin time values with two different reagents according to C-reactive protein values"],"prefix":"10.1093","volume":"56","author":[{"given":"Yuya","family":"Ishihara","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Fujita Health University Hospital , Toyoake ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Doi","sequence":"additional","affiliation":[{"name":"Department of Cellular and Molecular Biology, Fujita Health University School of Medical Sciences , Toyoake, Aichi ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiko","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Fujita Health University Hospital , Toyoake ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyasu","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Fujita Health University Hospital , Toyoake ,","place":["Japan"]},{"name":"Department of Joint Research Laboratory of Clinical Medicine, Fujita Health University School of Medicine , Toyoake ,","place":["Japan"]},{"name":"Department of Disease Systems Analysis Medicine, Fujita Health University School of Medical Sciences , Toyoake ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"issue":"4","key":"2025010605545442200_CIT0001","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/labmed\/lmx050","article-title":"Coagulation testing in the core laboratory","volume":"48","author":"Winter","year":"2017","journal-title":"Lab Med."},{"issue":"5","key":"2025010605545442200_CIT0002","doi-asserted-by":"publisher","first-page":"e8349","DOI":"10.7759\/cureus.8349","article-title":"Diagnostic pearls and clinical implications of Prekallikrein deficiency","volume":"12","author":"Yasin","year":"2020","journal-title":"Cureus"},{"issue":"2","key":"2025010605545442200_CIT0003","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jtha.2022.11.011","article-title":"Severe high-molecular-weight kininogen deficiency: clinical characteristics, deficiency-causing KNG1 variants, and estimated prevalence","volume":"21","author":"Adenaeuer","year":"2023","journal-title":"J Thromb Haemost."},{"issue":"3","key":"2025010605545442200_CIT0004","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/jth.13243","article-title":"Developments in the diagnostic procedures for von Willebrand disease","volume":"14","author":"De Jong","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2025010605545442200_CIT0005","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1365-2516.2009.02108.x","article-title":"Determinants of factor VIII plasma levels in carriers of haemophilia A and in control women","volume":"16","author":"Ay","year":"2010","journal-title":"Haemophilia"},{"issue":"4","key":"2025010605545442200_CIT0006","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s11239-021-02591-4","article-title":"Concomitant factor VIII inhibitor and lupus anticoagulant in an asymptomatic patient","volume":"53","author":"Jacobs","year":"2022","journal-title":"J Thromb Thrombolysis."},{"issue":"1","key":"2025010605545442200_CIT0007","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2147\/JBM.S273047","article-title":"DIC in pregnancy \u2013 pathophysiology, clinical characteristics, diagnostic scores, and treatments","volume":"13","author":"Erez","year":"2022","journal-title":"J Blood Med"},{"issue":"4","key":"2025010605545442200_CIT0008","first-page":"279","article-title":"Clinical evaluation of bleeding and bruising in primary care","volume":"93","author":"Neutze","year":"2016","journal-title":"Am Fam Physician."},{"issue":"1","key":"2025010605545442200_CIT0009","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5847\/wjem.j.1920-8642.2011.01.014","article-title":"Treatment of vitamin K-dependent coagulation factor deficiency and subarachnoid hemorrhage","volume":"2","author":"Chen","year":"2011","journal-title":"World J Emerg Med"},{"issue":"1","key":"2025010605545442200_CIT0010","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1186\/s12877-022-03327-6","article-title":"Neglected vitamin K deficiency causing coagulation dysfunction in an older patient with pneumonia: a case report","volume":"22","author":"Wu","year":"2022","journal-title":"BMC Geriatr."},{"issue":"2","key":"2025010605545442200_CIT0011","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/jcp.38.2.133","article-title":"ICSH\/ICTH recommendations for reporting prothrombin time in oral anticoagulant control","volume":"38","year":"1985","journal-title":"J Clin Pathol."},{"issue":"11","key":"2025010605545442200_CIT0012","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1111\/j.1538-7836.2012.04906.x","article-title":"APTT reagent with ellagic acid as activator shows adequate lupus anticoagulant sensitivity in comparison to silica-based reagent","volume":"10","author":"Kumano","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2025010605545442200_CIT0013","doi-asserted-by":"publisher","first-page":"e22415","DOI":"10.1002\/jcla.22415","article-title":"What should be the laboratory approach against isolated prolongation of a activated partial thromboplastin time","volume":"32","author":"Falay","year":"2018","journal-title":"J Clin Lab Anal."},{"key":"2025010605545442200_CIT0014","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.clinbiochem.2022.01.010","article-title":"Comparison of capillary and venous blood sampling for routine coagulation assays","volume":"104","author":"Fliervoet","year":"2022","journal-title":"Clin Biochem."},{"issue":"1","key":"2025010605545442200_CIT0015","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1136\/jcp.49.1.10","article-title":"Wide variability in the sensitivity of APTT reagents for monitoring of heparin dosage","volume":"49","author":"Kitchen","year":"1996","journal-title":"J Clin Pathol."},{"issue":"4","key":"2025010605545442200_CIT0016","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/ijlh.12499","article-title":"In vitro sensitivity of different activated partial thromboplastin time reagents to mild clotting factor deficiencies","volume":"38","author":"Toulon","year":"2016","journal-title":"Int J Lab Hematol."},{"issue":"3","key":"2025010605545442200_CIT0017","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1046\/j.1365-2141.1999.01596.x","article-title":"Lipid composition of seven APTT reagents in relation to heparin sensitivity","volume":"106","author":"Kitchen","year":"1999","journal-title":"Br J Haematol."},{"issue":"8","key":"2025010605545442200_CIT0018","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1111\/jth.15264","article-title":"APTT therapeutic range for monitoring unfractionated heparin therapy. Significant impact of the anti-Xa reagent used for correlation","volume":"19","author":"Toulon","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2025010605545442200_CIT0019","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/ijlh.13277","article-title":"The traceability of commercial plasma calibrators to the plasma international standards for factor VIII and factor IX","volume":"42","author":"Wilmot","year":"2020","journal-title":"Int J Lab Hematol."},{"key":"2025010605545442200_CIT0020","doi-asserted-by":"publisher","first-page":"320674","DOI":"10.1155\/2014\/320674","article-title":"Acquired hemophilia A: a frequently overlooked autoimmune hemorrhagic disorder","volume":"2014","author":"Sakurai","year":"2014","journal-title":"J Immunol Res"},{"issue":"4","key":"2025010605545442200_CIT0021","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/rth2.12245","article-title":"Ruling out lupus anticoagulants with mixing test\u2013specific cutoff assessment and the index of circulating anticoagulant","volume":"3","author":"Kumano","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"issue":"3","key":"2025010605545442200_CIT0022","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1365-2141.2011.08990.x","article-title":"False prolongation of the activated partial thromboplastin time (aPTT) in inflammatory patients: interference of C-reactive protein","volume":"157","author":"van Rossum","year":"2012","journal-title":"Br J Haematol."},{"issue":"8","key":"2025010605545442200_CIT0023","doi-asserted-by":"publisher","first-page":"e22571","DOI":"10.1002\/jcla.22571","article-title":"The analysis of false prolongation of the activated partial thromboplastin time (activator: silica): interference of C-reactive protein","volume":"32","author":"Liu","year":"2018","journal-title":"J Clin Lab Anal."},{"issue":"9","key":"2025010605545442200_CIT0024","doi-asserted-by":"publisher","first-page":"e24608","DOI":"10.1002\/jcla.24608","article-title":"Comparative analysis on characteristics of two activated partial thromboplastin time reagents","volume":"36","author":"Yasui","year":"2022","journal-title":"J Clin Lab Anal."},{"issue":"12","key":"2025010605545442200_CIT0025","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1172\/JCI18921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J Clin Invest."},{"issue":"2","key":"2025010605545442200_CIT0026","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/s0969-2126(99)80023-9","article-title":"The physiological structure of human C-reactive protein and its complex with phosphocholine","volume":"7","author":"Thompson","year":"1999","journal-title":"Structure."},{"issue":"1","key":"2025010605545442200_CIT0027","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ab.2009.04.037","article-title":"Characterization of Ca2+ and phosphocholine interactions with C-reactive protein using a surface plasmon resonance biosensor","volume":"391","author":"Christopeit","year":"2009","journal-title":"Anal Biochem."},{"issue":"2","key":"2025010605545442200_CIT0028","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2025010605545442200_CIT0029","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"21","key":"2025010605545442200_CIT0030","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1056\/NEJMra1705454","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"378","author":"Garcia","year":"2018","journal-title":"N Engl J Med."},{"issue":"2","key":"2025010605545442200_CIT0031","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/rth2.12090","article-title":"Effects of anti-\u03b22GPI antibodies on VWF release from human umbilical vein endothelial cells and ADAMTS13 activity","volume":"2","author":"Ng","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"issue":"1","key":"2025010605545442200_CIT0032","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11926-009-0075-4","article-title":"Impaired fibrinolysis in the antiphospholipid syndrome","volume":"12","author":"Krone","year":"2010","journal-title":"Curr Rheumatol Rep."},{"issue":"11","key":"2025010605545442200_CIT0033","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1111\/jth.15047","article-title":"Guidance from the Scientific and Standardization Committee for Lupus Anticoagulant\/Antiphospholipid Antibodies of the International Society on Thrombosis and Haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation","volume":"18","author":"Devreese","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2025010605545442200_CIT0034","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/joim.13126","article-title":"High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability","volume":"289","author":"Pineton de Chambrun","year":"2021","journal-title":"J Intern Med."},{"issue":"9","key":"2025010605545442200_CIT0035","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.1111\/jth.14980","article-title":"Lupus anticoagulant is frequent in patients with Covid-19: response to reply","volume":"18","author":"Harzallah","year":"2020","journal-title":"J Thromb Haemost."},{"issue":"3","key":"2025010605545442200_CIT0036","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1056\/NEJMc2013656","article-title":"Lupus anticoagulant and abnormal coagulation tests in patients with Covid-19","volume":"383","author":"Bowles","year":"2020","journal-title":"N Engl J Med."},{"issue":"6","key":"2025010605545442200_CIT0037","doi-asserted-by":"publisher","first-page":"e12809","DOI":"10.1002\/rth2.12809","article-title":"Lupus anticoagulant associates with thrombosis in patients with COVID-19 admitted to intensive care units: a retrospective cohort study","volume":"6","author":"Noordermeer","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"issue":"1","key":"2025010605545442200_CIT0038","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s11239-021-02485-5","article-title":"Transient endothelial injury and release of lupus anticoagulant in COVID-19","volume":"53","author":"Trimaille","year":"2022","journal-title":"J Thromb Thrombolysis."},{"issue":"1","key":"2025010605545442200_CIT0039","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1055\/s-0041-1729856","article-title":"Is lupus anticoagulant a significant feature of COVID-19? A critical appraisal of the literature","volume":"48","author":"Favaloro","year":"2022","journal-title":"Semin Thromb Hemost."},{"issue":"2","key":"2025010605545442200_CIT0040","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/ijlh.14003","article-title":"Lupus anticoagulants as a prospective independent predictor in COVID-19 patients","volume":"45","author":"Kim","year":"2022","journal-title":"Int J Lab Hematol."}],"container-title":["Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/56\/1\/7\/58979293\/lmae053.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/56\/1\/7\/58979293\/lmae053.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T05:54:59Z","timestamp":1736142899000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/labmed\/article\/56\/1\/7\/7746019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,8,30]]},"published-print":{"date-parts":[[2025,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/labmed\/lmae053","relation":{},"ISSN":["0007-5027","1943-7730"],"issn-type":[{"value":"0007-5027","type":"print"},{"value":"1943-7730","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,8,30]]}}}